• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

部分酶的可逆抑制及其代谢和药物毒理学意义。

Partial Reversible Inhibition of Enzymes and Its Metabolic and Pharmaco-Toxicological Implications.

机构信息

Biochemical Neuropharmacology Laboratory, Kazan Federal University, 18 ul. Kremlevskaya, 420008 Kazan, Russia.

出版信息

Int J Mol Sci. 2023 Aug 19;24(16):12973. doi: 10.3390/ijms241612973.

DOI:10.3390/ijms241612973
PMID:37629158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10454656/
Abstract

Partial reversible inhibition of enzymes, also called hyperbolic inhibition, is an uncommon mechanism of reversible inhibition, resulting from a productive enzyme-inhibitor complex. This type of inhibition can involve competitive, mixed, non-competitive and uncompetitive inhibitors. While full reversible inhibitors show linear plots for reciprocal enzyme initial velocity versus inhibitor concentration, partial inhibitors produce hyperbolic plots. Similarly, dose-response curves show residual fractional activity of enzymes at high doses. This article reviews the theory and methods of analysis and discusses the significance of this type of reversible enzyme inhibition in metabolic processes, and its implications in pharmacology and toxicology.

摘要

部分可逆抑制作用,也称双曲线抑制作用,是一种不常见的可逆抑制作用机制,由有活性的酶-抑制剂复合物产生。这种抑制作用可涉及竞争性、混合性、非竞争性和反竞争性抑制剂。虽然完全可逆抑制剂的酶初始速度与抑制剂浓度的倒数呈线性关系,但部分抑制剂产生双曲线关系。同样,剂量反应曲线显示高剂量下酶的剩余分数活性。本文综述了这种可逆酶抑制作用的理论和分析方法,并讨论了其在代谢过程中的意义,以及在药理学和毒理学中的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/480391ec620c/ijms-24-12973-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/e23c073a322b/ijms-24-12973-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/dd418cffe3f6/ijms-24-12973-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/aea2fc41a995/ijms-24-12973-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/c2bf74e1a0b3/ijms-24-12973-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/453a2c5e867a/ijms-24-12973-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/480391ec620c/ijms-24-12973-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/e23c073a322b/ijms-24-12973-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/dd418cffe3f6/ijms-24-12973-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/aea2fc41a995/ijms-24-12973-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/c2bf74e1a0b3/ijms-24-12973-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/453a2c5e867a/ijms-24-12973-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c6/10454656/480391ec620c/ijms-24-12973-g004.jpg

相似文献

1
Partial Reversible Inhibition of Enzymes and Its Metabolic and Pharmaco-Toxicological Implications.部分酶的可逆抑制及其代谢和药物毒理学意义。
Int J Mol Sci. 2023 Aug 19;24(16):12973. doi: 10.3390/ijms241612973.
2
The Relationship between the IC Values and the Apparent Inhibition Constant in the Study of Inhibitors of Tyrosinase Diphenolase Activity Helps Confirm the Mechanism of Inhibition.在研究酪氨酸酶二酚酶活性抑制剂时,IC 值与表观抑制常数之间的关系有助于确认抑制机制。
Molecules. 2022 May 13;27(10):3141. doi: 10.3390/molecules27103141.
3
The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.作用于单一酶的完全抑制剂和部分抑制剂之间的相互作用。理论分析。
Mol Pharmacol. 1983 Jul;24(1):30-41.
4
Potential misconceptions arising from the application of enzyme kinetic equations to ligand-receptor systems at equilibrium.在平衡状态下将酶动力学方程应用于配体-受体系统时可能产生的误解。
Can J Physiol Pharmacol. 1988 Apr;66(4):342-9. doi: 10.1139/y88-059.
5
A graphical method for determining inhibition parameters for partial and complete inhibitors.一种用于确定部分抑制剂和完全抑制剂抑制参数的图解方法。
Biochem J. 1987 Dec 15;248(3):815-20. doi: 10.1042/bj2480815.
6
Reversible Mechanisms of Enzyme Inhibition and Resulting Clinical Significance.酶抑制的可逆机制及由此产生的临床意义。
Methods Mol Biol. 2021;2342:29-50. doi: 10.1007/978-1-0716-1554-6_2.
7
Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.甲氧氯普胺的间接拟副交感神经活性:对人中枢神经系统和血液中胆碱酯酶的可逆性抑制。
Pharmacol Res. 1996 Jul-Aug;34(1-2):65-72. doi: 10.1006/phrs.1996.9999.
8
Mechanistic and kinetic studies of inhibition of enzymes.酶抑制作用的机理和动力学研究
Cell Biochem Biophys. 2000;33(3):217-25. doi: 10.1385/cbb:33:3:217.
9
Reversible mechanisms of enzyme inhibition and resulting clinical significance.酶抑制的可逆机制及其临床意义。
Methods Mol Biol. 2014;1113:37-56. doi: 10.1007/978-1-62703-758-7_4.
10
Progress-curve equations for reversible enzyme-catalysed reactions inhibited by tight-binding inhibitors.被紧密结合抑制剂抑制的可逆酶催化反应的进程曲线方程。
Biochem J. 1990 Feb 1;265(3):647-53. doi: 10.1042/bj2650647.

引用本文的文献

1
BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo.补中益气方通过体内外抑制α-淀粉酶和α-葡萄糖苷酶减轻2型糖尿病大鼠餐后高血糖。
Pharmaceuticals (Basel). 2025 Feb 2;18(2):201. doi: 10.3390/ph18020201.
2
FAT1 knockdown enhances the CSC properties of HNSCC through p-CaMKII-mediated inactivation of the IFN pathway.FAT1基因敲低通过p-CaMKII介导的干扰素途径失活增强头颈部鳞状细胞癌的癌症干细胞特性。
Int J Biol Sci. 2025 Jan 1;21(2):671-684. doi: 10.7150/ijbs.95723. eCollection 2025.
3
Effect of Genistein on Starch Digestion In Vitro and Its Mechanism of Action.

本文引用的文献

1
Activation/Inhibition of Cholinesterases by Excess Substrate: Interpretation of the Phenomenological Factor in Steady-State Rate Equation.过量底物对胆碱酯酶的激活/抑制:稳态速率方程中现象学因子的解释。
Int J Mol Sci. 2023 Jun 21;24(13):10472. doi: 10.3390/ijms241310472.
2
Effect of cytochrome P450 inhibition on toxicity of diclofenac in chickens: Unravelling toxicity in Gyps vultures.细胞色素 P450 抑制对鸡中二氯芬酸毒性的影响:揭开秃鹫中毒的真相。
Onderstepoort J Vet Res. 2022 Jun 14;89(1):e1-e8. doi: 10.4102/ojvr.v89i1.1978.
3
Models of enzyme inhibition and apparent dissociation constants from kinetic analysis to study the differential inhibition of aldose reductase.
染料木黄酮对体外淀粉消化的影响及其作用机制
Foods. 2024 Sep 4;13(17):2809. doi: 10.3390/foods13172809.
4
Magnesium enhances aurintricarboxylic acid's inhibitory action on the plasma membrane Ca-ATPase.镁增强了奥曲酸对质膜 Ca-ATP 酶的抑制作用。
Sci Rep. 2024 Jun 26;14(1):14693. doi: 10.1038/s41598-024-65465-8.
5
Correlation of Experimental and Calculated Inhibition Constants of Protease Inhibitor Complexes.实验和计算的蛋白酶抑制剂复合物抑制常数的相关性。
Int J Mol Sci. 2024 Feb 19;25(4):2429. doi: 10.3390/ijms25042429.
从动力学分析研究醛糖还原酶的差异抑制作用的酶抑制模型和表观离解常数。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1426-1436. doi: 10.1080/14756366.2022.2076089.
4
Mechanism of dasabuvir inhibition of acetaminophen glucuronidation.达沙布韦抑制对乙酰氨基酚葡萄糖醛酸化的作用机制。
J Pharm Pharmacol. 2022 Jan 5;74(1):131-138. doi: 10.1093/jpp/rgab144.
5
Steady-state kinetic analysis of human cholinesterases over wide concentration ranges of competing substrates.在广泛的竞争底物浓度范围内对人胆碱酯酶的稳态动力学分析。
Biochim Biophys Acta Proteins Proteom. 2022 Jan;1870(1):140733. doi: 10.1016/j.bbapap.2021.140733. Epub 2021 Oct 16.
6
Substrate inhibition by the blockage of product release and its control by tunnel engineering.通过产物释放受阻导致的底物抑制及其通过通道工程进行的控制。
RSC Chem Biol. 2021 Jan 11;2(2):645-655. doi: 10.1039/d0cb00171f. eCollection 2021 Apr 1.
7
A guide to the Michaelis-Menten equation: steady state and beyond.米氏方程指南:稳态及其他。
FEBS J. 2022 Oct;289(20):6086-6098. doi: 10.1111/febs.16124. Epub 2021 Jul 31.
8
The multiple biological roles of the cholinesterases.胆碱酯酶的多种生物学作用。
Prog Biophys Mol Biol. 2021 Jul;162:41-56. doi: 10.1016/j.pbiomolbio.2020.12.001. Epub 2020 Dec 8.
9
Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice.部分抑制糖酵解可减少小鼠斑块内新生血管形成,从而减少动脉粥样硬化的发生。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1168-1181. doi: 10.1161/ATVBAHA.119.313692. Epub 2020 Mar 19.
10
Time-course of human cholinesterases-catalyzed competing substrate kinetics.人胆碱酯酶催化竞争底物动力学的时程。
Chem Biol Interact. 2019 Sep 1;310:108702. doi: 10.1016/j.cbi.2019.06.015. Epub 2019 Jun 24.